Global Genetic Disease Diagnostic 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR012511612

Publication Date:

January 29, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Genetic Disease Diagnostic market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Hereditary diseases are those caused by changes in genetic material or controlled by disease-causing genes. Hereditary diseases refer to diseases that are determined wholly or partly by genetic factors, usually congenital or acquired. Be like congenital foolish model, much point to (toe), congenital deafness dumb, hemophilia, these hereditary disease decides to come on completely by genetic factor, and just after be born certain time comes on, want to pass a few years sometimes, more than ten years even ability after decades appears apparent symptom.At present, China has adopted a variety of neonatal disease screening technologies for early diagnosis and treatment of children with genetic diseases without clinical symptoms, effectively reducing the disability rate and mortality rate of children, and greatly reducing the serious harm caused by birth defects to families and society. In recent years, with the rapid development of molecular biology and genomics, genetic testing technology has become the gold standard when it comes to most of the hereditary disease diagnosis, especially in the biochemical or enzymatic method can"t make a diagnosis and test results under the condition of not clear, genetic testing is an important means of diagnosis, but in the field of neonatal hereditary disease screening, genetic testing technology is not yet ripe for applications, Gene screening for neonatal deafness has been reported in China.
In China markets, the core manufacturers of genetic disease diagnostic includes BGI Group, Berry Genomics etc and the top 5 companies hold a share over 40%.
This report is a detailed and comprehensive analysis for global Genetic Disease Diagnostic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Genetic Disease Diagnostic market size and forecasts, in consumption value ($ Million), 2020-2031
Global Genetic Disease Diagnostic market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Genetic Disease Diagnostic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Genetic Disease Diagnostic market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genetic Disease Diagnostic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genetic Disease Diagnostic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Genetic Disease Diagnostic market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
麻豆原创 segment by Application
Hospital
Medical Laboratory
Others
麻豆原创 segment by players, this report covers
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genetic Disease Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genetic Disease Diagnostic, with revenue, gross margin, and global market share of Genetic Disease Diagnostic from 2020 to 2025.
Chapter 3, the Genetic Disease Diagnostic competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Genetic Disease Diagnostic market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genetic Disease Diagnostic.
Chapter 13, to describe Genetic Disease Diagnostic research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Genetic Disease Diagnostic by Type
1.3.1 Overview: Global Genetic Disease Diagnostic 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Genetic Disease Diagnostic Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Prenatal Diagnosis
1.3.4 Screening for Single Gene Genetic Disease
1.3.5 Preimplantation Genetic Testing
1.3.6 Others
1.4 Global Genetic Disease Diagnostic 麻豆原创 by Application
1.4.1 Overview: Global Genetic Disease Diagnostic 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Medical Laboratory
1.4.4 Others
1.5 Global Genetic Disease Diagnostic 麻豆原创 Size & Forecast
1.6 Global Genetic Disease Diagnostic 麻豆原创 Size and Forecast by Region
1.6.1 Global Genetic Disease Diagnostic 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Genetic Disease Diagnostic 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Genetic Disease Diagnostic 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Genetic Disease Diagnostic 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Genetic Disease Diagnostic 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Genetic Disease Diagnostic 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Genetic Disease Diagnostic 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Genetic Disease Diagnostic Product and Solutions
2.1.4 Abbott Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Abbott Recent Developments and Future Plans
2.2 PerkinElmer
2.2.1 PerkinElmer Details
2.2.2 PerkinElmer Major Business
2.2.3 PerkinElmer Genetic Disease Diagnostic Product and Solutions
2.2.4 PerkinElmer Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 PerkinElmer Recent Developments and Future Plans
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics Genetic Disease Diagnostic Product and Solutions
2.3.4 Roche Diagnostics Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Roche Diagnostics Recent Developments and Future Plans
2.4 Bio Rad
2.4.1 Bio Rad Details
2.4.2 Bio Rad Major Business
2.4.3 Bio Rad Genetic Disease Diagnostic Product and Solutions
2.4.4 Bio Rad Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Bio Rad Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Product and Solutions
2.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 BGI Group
2.6.1 BGI Group Details
2.6.2 BGI Group Major Business
2.6.3 BGI Group Genetic Disease Diagnostic Product and Solutions
2.6.4 BGI Group Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 BGI Group Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics Genetic Disease Diagnostic Product and Solutions
2.7.4 Berry Genomics Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Da An Gene Co., Ltd.
2.8.1 Da An Gene Co., Ltd. Details
2.8.2 Da An Gene Co., Ltd. Major Business
2.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Product and Solutions
2.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Da An Gene Co., Ltd. Recent Developments and Future Plans
2.9 Illumina
2.9.1 Illumina Details
2.9.2 Illumina Major Business
2.9.3 Illumina Genetic Disease Diagnostic Product and Solutions
2.9.4 Illumina Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Illumina Recent Developments and Future Plans
2.10 CapitalBio Technology
2.10.1 CapitalBio Technology Details
2.10.2 CapitalBio Technology Major Business
2.10.3 CapitalBio Technology Genetic Disease Diagnostic Product and Solutions
2.10.4 CapitalBio Technology Genetic Disease Diagnostic Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 CapitalBio Technology Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Genetic Disease Diagnostic Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Genetic Disease Diagnostic by Company Revenue
3.2.2 Top 3 Genetic Disease Diagnostic Players 麻豆原创 Share in 2024
3.2.3 Top 6 Genetic Disease Diagnostic Players 麻豆原创 Share in 2024
3.3 Genetic Disease Diagnostic 麻豆原创: Overall Company Footprint Analysis
3.3.1 Genetic Disease Diagnostic 麻豆原创: Region Footprint
3.3.2 Genetic Disease Diagnostic 麻豆原创: Company Product Type Footprint
3.3.3 Genetic Disease Diagnostic 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Genetic Disease Diagnostic Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Genetic Disease Diagnostic 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Genetic Disease Diagnostic Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Genetic Disease Diagnostic 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Genetic Disease Diagnostic Consumption Value by Type (2020-2031)
6.2 North America Genetic Disease Diagnostic 麻豆原创 Size by Application (2020-2031)
6.3 North America Genetic Disease Diagnostic 麻豆原创 Size by Country
6.3.1 North America Genetic Disease Diagnostic Consumption Value by Country (2020-2031)
6.3.2 United States Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Genetic Disease Diagnostic Consumption Value by Type (2020-2031)
7.2 Europe Genetic Disease Diagnostic Consumption Value by Application (2020-2031)
7.3 Europe Genetic Disease Diagnostic 麻豆原创 Size by Country
7.3.1 Europe Genetic Disease Diagnostic Consumption Value by Country (2020-2031)
7.3.2 Germany Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnostic Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Genetic Disease Diagnostic Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Genetic Disease Diagnostic 麻豆原创 Size by Region
8.3.1 Asia-Pacific Genetic Disease Diagnostic Consumption Value by Region (2020-2031)
8.3.2 China Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Genetic Disease Diagnostic Consumption Value by Type (2020-2031)
9.2 South America Genetic Disease Diagnostic Consumption Value by Application (2020-2031)
9.3 South America Genetic Disease Diagnostic 麻豆原创 Size by Country
9.3.1 South America Genetic Disease Diagnostic Consumption Value by Country (2020-2031)
9.3.2 Brazil Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Genetic Disease Diagnostic Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Genetic Disease Diagnostic Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Genetic Disease Diagnostic 麻豆原创 Size by Country
10.3.1 Middle East & Africa Genetic Disease Diagnostic Consumption Value by Country (2020-2031)
10.3.2 Turkey Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Genetic Disease Diagnostic 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Genetic Disease Diagnostic 麻豆原创 Drivers
11.2 Genetic Disease Diagnostic 麻豆原创 Restraints
11.3 Genetic Disease Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Genetic Disease Diagnostic Industry Chain
12.2 Genetic Disease Diagnostic Upstream Analysis
12.3 Genetic Disease Diagnostic Midstream Analysis
12.4 Genetic Disease Diagnostic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.